Saygin, C., Larkin, K., Blachly, J. S., Orwick, S., Ngankeu, A., Gregory, C. T., Phelps, M. A., Mani, S., Walker, A., Garzon, R., Vasu, S., Walsh, K. J., Bhatnagar, B., Klisovic, R. B., Grever, M. R., Marcucci, G., Byrd, J. C., Blum, W., & Mims, A. S. (n.d.). a phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome. American journal of hematology, 95(12), 1457–1465. http://access.bl.uk/ark:/81055/vdc_100115876019.0x00002e